References of "CAVALIER, Etienne"
     in
Bookmark and Share    
See detailCurrent analytical aspects of vitamin D
Cavalier, Etienne ULg

Conference (2010, October 07)

Detailed reference viewed: 20 (2 ULg)
Full Text
See detailVascular calcifications in dialysis patients
Delanaye, Pierre ULg; Cavalier, Etienne ULg

Learning material (2010)

Detailed reference viewed: 11 (2 ULg)
Full Text
See detailNew technologies in allergology, Workshop
Gadisseur, Romy ULg; Chapelle, Jean-Paul ULg; Cavalier, Etienne ULg

Conference (2010, October)

Detailed reference viewed: 9 (1 ULg)
Full Text
Peer Reviewed
See detailAldosterone and parathyroid hormone: a complex and clinically relevant relationship
Pilz, Stefan; Tomaschitz, Andreas; März, Winfried et al

in Calcified Tissue International (2010), 87(4), 373-4

Detailed reference viewed: 13 (2 ULg)
See detailLa vitamine D: le point en 2010.
Cavalier, Etienne ULg

Conference (2010, September 17)

Detailed reference viewed: 28 (1 ULg)
Full Text
Peer Reviewed
See detailDosage de la 25-OH vitamine D: attention aux erreurs analytiques!
Cavalier, Etienne ULg; Carlisi, Ignazia ULg; Delanaye, Pierre ULg et al

in 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September)

Detailed reference viewed: 72 (3 ULg)
Full Text
Peer Reviewed
See detailLes cibles thérapeutiques pour la PTH dans les nouvelles recommandations du KDIGO: la fin d'un cauchemar?
Cavalier, Etienne ULg; Jean, G.; Delanaye, Pierre ULg et al

in Néphrologie & Thérapeutique (2010, September), 6(5), 424

Detailed reference viewed: 26 (1 ULg)
Full Text
Peer Reviewed
See detailEvaluation analytique de la cystatine C: résultats de l'étude multicentrique SN/SFBC
Cavalier, Etienne ULg; Barguil, Y.; Bourgeois, A. M. et al

in Néphrologie & Thérapeutique (2010, September), 6(5), 314

Detailed reference viewed: 25 (2 ULg)
Full Text
Peer Reviewed
See detailQuels paramètres cliniques et biologiques peuvent être considérés comme prédictifs des calcifications vasculaires chez le patient hémodialysé?
Delanaye, Pierre ULg; Warling, X.; Moonen, M. et al

in Néphrologie & Thérapeutique (2010, September), 6(5), 296

Detailed reference viewed: 22 (6 ULg)
Full Text
Peer Reviewed
See detailLe dosage urinaire et plasmatique du NGAL: étude analytique et implications pratiques pour le clinicien
Cavalier, Etienne ULg; Rozet, Eric ULg; Bekaert, Anne-Catherine ULg et al

in Néphrologie & Thérapeutique (2010, September), 6(5), 350

Detailed reference viewed: 62 (2 ULg)
Full Text
Peer Reviewed
See detailComparaison d'une méthode "acide" et enzymatique pour le dosage de l'inuline
Thibaudin, L.; Delanaye, Pierre ULg; Maillard, N. et al

in Néphrologie & Thérapeutique (2010, September), 6(5), 316

Detailed reference viewed: 15 (1 ULg)
Full Text
Peer Reviewed
See detailDosage de la vitamine D : attention aux erreurs analytiques!
Cavalier, Etienne ULg; Carlisi, A.; Delanaye, Pierre ULg et al

in Annales d'Endocrinologie (2010, September), 71(5), 368

Detailed reference viewed: 34 (4 ULg)
Full Text
Peer Reviewed
See detailUn nouveau marqueur tumoral pour le carcinome parathyroïdien? Résultats observés chez 24 patients
Cavalier, Etienne ULg; Daly, Adrian ULg; Betea, Daniela ULg et al

in Annales d'Endocrinologie (2010, September), 71(5), 350-351

Detailed reference viewed: 15 (2 ULg)
Full Text
Peer Reviewed
See detailVitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice.
Souberbielle, J. C.; Body, J. J.; Lappe, J. M. et al

in Autoimmunity Reviews (2010), 9(11), 709-15

BACKGROUND: There is increasing evidence that, in addition to the well-known effects on musculoskeletal health, vitamin D status may be related to a number of non-skeletal diseases. An international ... [more ▼]

BACKGROUND: There is increasing evidence that, in addition to the well-known effects on musculoskeletal health, vitamin D status may be related to a number of non-skeletal diseases. An international expert panel formulated recommendations on vitamin D for clinical practice, taking into consideration the best evidence available based on published literature today. In addition, where data were limited to smaller clinical trials or epidemiologic studies, the panel made expert-opinion based recommendations. METHODS: Twenty-five experts from various disciplines (classical clinical applications, cardiology, autoimmunity, and cancer) established draft recommendations during a 2-day meeting. Thereafter, representatives of all disciplines refined the recommendations and related texts, subsequently reviewed by all panelists. For all recommendations, panelists expressed the extent of agreement using a 5-point scale. RESULTS AND CONCLUSION: Recommendations were restricted to clinical practice and concern adult patients with or at risk for fractures, falls, cardiovascular or autoimmune diseases, and cancer. The panel reached substantial agreement about the need for vitamin D supplementation in specific groups of patients in these clinical areas and the need for assessing their 25-hydroxyvitamin D (25(OH)D) serum levels for optimal clinical care. A target range of at least 30 to 40 ng/mL was recommended. As response to treatment varies by environmental factors and starting levels of 25(OH)D, testing may be warranted after at least 3 months of supplementation. An assay measuring both 25(OH)D(2) and 25(OH)D(3) is recommended. Dark-skinned or veiled individuals not exposed much to the sun, elderly and institutionalized individuals may be supplemented (800 IU/day) without baseline testing. [less ▲]

Detailed reference viewed: 48 (4 ULg)
Full Text
Peer Reviewed
See detailAnalytical validation of the Liaison hGH assay (DiaSorin)
Keutgens, Aurore ULg; Ho, Thi Thanh Giang ULg; Cavalier, Etienne ULg

in European NeuroEndocrine Association (2010, September)

Detailed reference viewed: 41 (4 ULg)
Full Text
See detailVitamin D and cardiovascular diseases: Where do we stand in 2010?
Cavalier, Etienne ULg

in Lipid Club Letter (2010), 22(3), 2-3

Detailed reference viewed: 30 (0 ULg)